Home/Pipeline/Stem cell therapy

Stem cell therapy

Neurodegenerative diseases

PreclinicalActive

Key Facts

Indication
Neurodegenerative diseases
Phase
Preclinical
Status
Active
Company

About Regencell Bioscience

Regencell Bioscience combines traditional Chinese medicine with modern biotechnology to develop innovative treatments for autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), and other neurodegenerative conditions. The company operates through its proprietary TCM-based formulations and stem cell therapy platforms, targeting underserved patient populations with limited treatment options. Based in Hong Kong, Regencell aims to bridge Eastern traditional medicine with Western regulatory standards to bring novel therapeutics to global markets.

View full company profile

Other Neurodegenerative diseases Drugs

DrugCompanyPhase
ANAVEX®1-41Anavex Life SciencesPreclinical